These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 4447892

  • 21. [Morphometric studies in early stages of renal osteopathy (author's transl)].
    Hufnagl HD, Hausen M, Traut G, Meiser RJ.
    Klin Wochenschr; 1974 Nov 15; 52(22):1070-7. PubMed ID: 4444223
    [No Abstract] [Full Text] [Related]

  • 22. Alkaline phosphatase bone isoenzyme activity in serum in various degrees of micromorphometrically assessed renal osteopathy.
    Siede WH, Seiffert UB, Bundschuh F, Malluche HH, Schoeppe W.
    Clin Nephrol; 1980 Jun 15; 13(6):277-81. PubMed ID: 7408246
    [Abstract] [Full Text] [Related]

  • 23. Bone disease in renal failure. Clinical and histomorphometric studies.
    Nilsson P.
    Scand J Urol Nephrol Suppl; 1984 Jun 15; 84():1-68. PubMed ID: 6393322
    [Abstract] [Full Text] [Related]

  • 24. Quantitative bone histology in acute renal failure.
    Zech P, Meunier P, Beruard M, Edouard C, Pozet N, Traeger J.
    Proc Eur Dial Transplant Assoc; 1973 Jun 15; 10(0):316-23. PubMed ID: 4802571
    [No Abstract] [Full Text] [Related]

  • 25. Evidence that different vitamin D sterols have qualitatively different effects in man.
    Rasmussen H, Bordier P.
    Contrib Nephrol; 1980 Jun 15; 18():184-91. PubMed ID: 7353375
    [No Abstract] [Full Text] [Related]

  • 26. Therapeutic effects of 25-hydroxycholecalciferol and sodium etidronate on renal osteodystrophy.
    Zucchelli P, Catizone L, Casanova S, Fabbri L, Fusaroli M.
    Miner Electrolyte Metab; 1982 Feb 15; 7(2):86-96. PubMed ID: 6820473
    [Abstract] [Full Text] [Related]

  • 27. Renal osteodystrophy in course of periodic dialysis for chronic uremia.
    Kim D, Bell NH, Bundesen W, Putong P, Simon NM, Walker C, Del Greco F.
    Trans Am Soc Artif Intern Organs; 1968 Feb 15; 14():367-71. PubMed ID: 5701557
    [No Abstract] [Full Text] [Related]

  • 28. Is calcitonin a helper of phosphate binders in the control of renal osteodystrophy?
    Ionova D, Zlatarska S, Kirjakov Z.
    Nephrol Dial Transplant; 1995 Feb 15; 10(9):1782. PubMed ID: 8559512
    [No Abstract] [Full Text] [Related]

  • 29. Skeletal abnormalities in chronic renal insufficiency before and during maintenance hemodialysis.
    Ritz E, Krempien B, Mehls O, Malluche H.
    Kidney Int; 1973 Aug 15; 4(2):116-27. PubMed ID: 4790866
    [No Abstract] [Full Text] [Related]

  • 30. Useful biochemical markers for diagnosing renal osteodystrophy in predialysis end-stage renal failure patients.
    Bervoets AR, Spasovski GB, Behets GJ, Dams G, Polenakovic MH, Zafirovska K, Van Hoof VO, De Broe ME, D'Haese PC.
    Am J Kidney Dis; 2003 May 15; 41(5):997-1007. PubMed ID: 12722034
    [Abstract] [Full Text] [Related]

  • 31. Imaging of bone in the diagnostics of renal osteodystrophy in children with chronic renal failure.
    Ziółkowska H, Pańczyk-Tomaszewska M, Majkowska Z, Rajkowski T, Debiński A, Przedlacki J, Sawicki A, Ostrowski K, Marciński A, Roszkowska-Blaim M.
    Med Sci Monit; 2001 May 15; 7(5):1034-42. PubMed ID: 11535955
    [Abstract] [Full Text] [Related]

  • 32. Bone histomorphometry in hemodialysed patients.
    de Vernejoul MC, Kuntz D, Miravet L, Gueris J, Bielakoff J, Ryckewaert A.
    Metab Bone Dis Relat Res; 1981 May 15; 3(3):175-9. PubMed ID: 7347793
    [Abstract] [Full Text] [Related]

  • 33. [Surgical treatment of secondary hyperparathyroidism].
    D'Alonzo U.
    Minerva Med; 1985 Mar 10; 76(9-10):389-91. PubMed ID: 3982695
    [No Abstract] [Full Text] [Related]

  • 34. Bisphosphonate kinetics in patients undergoing continuous ambulatory peritoneal dialysis: relations to dynamic bone histomorphometry, osteocalcin and parathyroid hormone.
    Joffe P, Hyldstrup L, Heaf JG, Pødenphant J, Henriksen JH.
    Am J Nephrol; 1992 Mar 10; 12(6):419-24. PubMed ID: 1292341
    [Abstract] [Full Text] [Related]

  • 35. Evolution of renal osteodystrophy: correlation of bone histomorphometry and serum mineral and immunoreactive parathyroid hormone values before and after treatment with calcium carbonate or 25-hydroxycholecalciferol.
    Bordier PJ, Marie PJ, Arnaud CD.
    Kidney Int Suppl; 1975 Jan 10; (2):102-12. PubMed ID: 1057669
    [No Abstract] [Full Text] [Related]

  • 36. ROLE OF PHOSPHATE IN TREATMENT OF RENAL TUBULAR (HYPOPHOSPHATAEMIC) RICKETS AND OSTEOMALACIAS.
    ROSE GA.
    Br Med J; 1964 Oct 03; 2(5413):857-61. PubMed ID: 14185638
    [No Abstract] [Full Text] [Related]

  • 37. The influence of a high calcium carbonate intake on bone disease in patients undergoing hemodialysis.
    Meyrier A, Marsac J, Richet G.
    Kidney Int; 1973 Aug 03; 4(2):146-53. PubMed ID: 4744972
    [No Abstract] [Full Text] [Related]

  • 38. Studies of bone morphology, bone densitometry and laboratory data in patients on maintenance hemodialysis treatment.
    Lindergård B, Johnell O, Nilsson BE, Wiklund PE.
    Nephron; 1985 Aug 03; 39(2):122-9. PubMed ID: 3974774
    [Abstract] [Full Text] [Related]

  • 39. Plasma hydroxyproline in uremia: relationships with histologic and biological indices of bone turnover.
    Cundy T, Bartlett M, Bishop M, Earnshaw M, Smith R, Kanis JA.
    Metab Bone Dis Relat Res; 1983 Aug 03; 4(5):297-303. PubMed ID: 6621355
    [No Abstract] [Full Text] [Related]

  • 40. Bone alkaline phosphatase isoforms in hemodialysis patients with low versus non-low bone turnover: a diagnostic test study.
    Haarhaus M, Monier-Faugere MC, Magnusson P, Malluche HH.
    Am J Kidney Dis; 2015 Jul 03; 66(1):99-105. PubMed ID: 25843703
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.